White Papers

1. The Case For A New Paradigm In Geographic Atrophy Clinical Trials 10/15/2025

   Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.

2. Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success 10/15/2025

   The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.

3. Eliminate Clinical Trial White Space With The Right AI Strategy 10/9/2025

   Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.

4. Gene Therapies For Rare Diseases: Advances In Platforms, Modalities, And Delivery Systems 10/6/2025

   Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.

5. Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers 9/30/2025

   Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.

6. How AI Is Reshaping Trial Design, Execution, And Disclosure 9/25/2025

   AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.

7. Decentralized And Community-Based Solutions Driving Women's Healthcare 9/24/2025

   Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.

8. Achieving End-To-End Clinical Supply Chain Visibility 9/23/2025

   Transform supply chain management by integrating technology solutions and real-time insights to link patient-level data with upstream manufacturing operations.

9. A Guide To Streamlining Study Start-Up In Australia 9/23/2025

   Discover the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.

10. The Hidden Problem In Early Phase Oncology Trials 9/23/2025

    Integrating patient-reported outcome measures (PROMs) can enable improved capture tolerability and optimize dosing decisions.